CXCL9 and neoplasm: Immune Response and Prognosis: CXCL9, CXCL10, and CXCL13 are linked to favorable prognosis due to their role in enhancing the immune response at the tumor site, suggesting their potential as biomarkers for immune contexture in cancer.